Fierce Biotech News & Reports
WEBBiopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on Fierce Biotech as their must-read source for the latest news, analysis and data in the world of biotech ...
MedTech | Fierce Biotech
WEB5 days ago · The agency labeled the recall effort as Class I, its most serious, and said it received reports of nine injuries and one death.
AstraZeneca's '2.0' cancer pipeline built on bispecifics - Fierce …
WEBOct 24, 2023 · AstraZeneca believes it has a unique approach, in part due to its proprietary bispecific platform, which has allowed the pharma to introduce fewer mutations that are needed to create the correct ...
Novo Nordisk unveils new US hub as R&D investments soar
WEBFeb 29, 2024 · The focus remains on treating cardiometabolic disease, namely obesity, diabetes and liver disease. Schindler, who joined Novo in 2018 after working at AstraZeneca, said there’s now a hype in the ...
FDA OKs Neuralace’s nerve stimulation tech for diabetes pain
WEBJan 11, 2024 · In mid-2021, after a decade of R&D, Neuralace Medical earned FDA clearance for its Axon Therapy, a noninvasive treatment option for chronic pain caused by nerve damage.
Altos bursts out of stealth with $3B, a dream team C-suite and a …
WEBJan 19, 2022 · RELATED: Barron quits GSK to take CEO post at $3B biotech startup The team will use $3 billion in capital committed by investors including Arch Venture Partners to try to turn breakthroughs in our ...
Biotech | Fierce Biotech
WEBFeb 12, 2024 · The GPCR specialist is asking investors to fund its lead hypoparathyroidism candidate through phase 2 before it shares initial data in humans.
Regeneron to fill gaps in obesity, break ground in cell therapy
WEBFeb 2, 2024 · Regeneron wants to improve on obesity care with a muscle-preservation approach, while elsewhere, the biopharma charts a new course in cell therapy.
New AI drug discovery powerhouse Xaira rises with $1B in funding
WEBApr 24, 2024 · Headquartered in the San Francisco Bay Area, Xaira will combine machine learning, data generation and therapeutic product development to build a platform for drug discovery.
PerkinElmer completes $2.45B split into two separate companies
WEBMar 14, 2023 · Under the terms of the deal laid out last year, New Mountain offered up $2.3 billion in upfront cash to take over the trio of PerkinElmer businesses, which produce hardware used in food safety ...